N-Nitroso Nilotinib Impurity 2
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

N-Nitroso Nilotinib Impurity 2

● Auf Lager

Katalog-Nr.::VE0023790
CAS-Nr.::N/A
Summenformel::C9H9N3O2
Molare Masse::191.2 g/mol

Zusätzliche Informationen zu N-Nitroso Nilotinib Impurity 2

Parent drug

Nilotinib

IUPAC-Name

N-Methyl-N-(3-oxo-3-(pyridin-3-yl)prop-1-en-1-yl)nitrous amide

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

O=NN(C)/C=C/C(C1=CC=CN=C1)=O

InChI

InChI=1S/C9H9N3O2/c1-12(11-14)6-4-9(13)8-3-2-5-10-7-8/h2-7H, 1H3/b6-4+

Beschreibung

N-Nitroso Nilotinib Impurity 2 is an N-nitroso derivative of the secondary amine present in Nilotinib | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Nilotinib production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url